Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InterMedical Care and Lab Hospital PCLBKK:IMH-R 70 3-Year Revenue Growth Rate is 3.60% as of Jun. 2026, which is 57% below its 10-year median of 8.35. GuruFocus rates BKK:IMH-R with a GF Score™ of 70/100 and a GF Value™ of ฿5.85 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 609 Healthcare Providers & Services companies, InterMedical Care and Lab Hospital PCL ranks worse than 59.77% on this metric.
During the past 12 months, InterMedical Care and Lab Hospital PCL's average Revenue per Share Growth Rate was -2.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of InterMedical Care and Lab Hospital PCL was 43.40% per year. The lowest was -7.00% per year. And the median was 8.35% per year.
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
InterMedical Care and Lab Hospital PCL 3-Year Revenue Growth Rate Related Terms
BKK:IMH-R vs HCA, THC, EHC: 3-Year Revenue Growth Rate Comparison
For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InterMedical Care and Lab Hospital PCL 3-Year Revenue Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where InterMedical Care and Lab Hospital PCL's 3-Year Revenue Growth Rate falls into.
InterMedical Care and Lab Hospital PCL 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 3.60% mean?
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) has a 3-Year Revenue Growth Rate of 3.60% as of Jun. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for InterMedical Care and Lab Hospital PCL and its competitors. This is 57% below median its historical median of 8.35. According to the industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #364 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 59.8%.
Is InterMedical Care and Lab Hospital PCL's 3-Year Revenue Growth Rate too high?
InterMedical Care and Lab Hospital PCL's current 3-Year Revenue Growth Rate of 3.60% is 57% below median its 10-year median of 8.35. The Healthcare Providers & Services industry median 3-Year Revenue Growth Rate is 7.00. InterMedical Care and Lab Hospital PCL's value of 3.60% is 48.6% below this industry median. Based on the distribution chart, InterMedical Care and Lab Hospital PCL ranks #364 out of 609 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's 3-Year Revenue Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #364 out of 609 companies for 3-Year Revenue Growth Rate. This places InterMedical Care and Lab Hospital PCL in the lower half of its industry. The industry median 3-Year Revenue Growth Rate is 7.00. InterMedical Care and Lab Hospital PCL's value of 3.60% is 48.6% below this benchmark. While the company's 10-year median is 8.35 vs. the industry median of 7.00, InterMedical Care and Lab Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Revenue Growth Rate among Healthcare Providers & Services companies is 7.00, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InterMedical Care and Lab Hospital PCL's current 3-Year Revenue Growth Rate of 3.60% is 48.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for InterMedical Care and Lab Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Revenue Growth Rate is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InterMedical Care and Lab Hospital PCL's current 3-Year Revenue Growth Rate is 3.60%, which is 57% below median its own 10-year median of 8.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH-R) is currently considered Possible Value Trap. The stock's GF Value™ is ฿5.85, compared to a current price of ฿3.62 — trading 38.1% below its estimated fair value. The current 3-Year Revenue Growth Rate is 3.60%, which is 57% below median its 10-year median of 8.35 and 48.6% below the Healthcare Providers & Services industry median of 7.00. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH-R), the current 3-Year Revenue Growth Rate is 3.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.62 is trading 38.1% below its estimated GF Value™ of ฿5.85.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:IMH-R:
3-Year Revenue Growth Rate: 3.60% (57% below median its 10-year median of 8.35)
GF Value™: ฿5.85 vs. price of ฿3.62 (38.1% below fair value)
Industry Position: 48.6% below the Healthcare Providers & Services median (#364 of 609)
No single metric tells the full story. See the BKK:IMH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
70GF Score
Get the complete analysis for BKK:IMH-R
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH-R has been successfully added to your 
